in

ROSEN, A TOP RANKED FIRM, Encourages NRx Pharmaceuticals, Inc. Investors With Losses Over $100K to Secure Counsel Before Important March 21 Deadline in Securities Class Action – NRXP, NRXPW

NEW YORK, March 12, 2022 /PRNewswire/ — WHY: New York, N.Y., March 12, 2022. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP, NRXPW) between June 1, 2021 and November 4, 2021, inclusive (the “Class Period”), of the important March 21, 2022 lead plaintiff deadline.


Rosen Law Firm, P.A. Logo

SO WHAT: If you purchased NRx securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the NRx class action, go to https://rosenlegal.com/submit-form/?case_id=3121 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 21, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the ZYESAMI Emergency Use Application (“EUA”) contained insufficient data regarding the potential benefits and risks of ZYESAMI; (2) accordingly, the U.S. Food and Drug Administration was unlikely to approve the ZYESAMI EUA in its present form; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the NRx class action, go to https://rosenlegal.com/submit-form/?case_id=3121 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/rosen-a-top-ranked-firm-encourages-nrx-pharmaceuticals-inc-investors-with-losses-over-100k-to-secure-counsel-before-important-march-21-deadline-in-securities-class-action–nrxp-nrxpw-301501220.html

SOURCE Rosen Law Firm, P.A.

Written by Tenner Smith

Tenner Smith - I have experience in financial intelligence and automated intelligence. In industry I have worked on artificial intelligence and machine learning. Tenner Smith is a reporter at DF media.

EMERGE Announces Advisory Engagement and Shares for Services Arrangement

Western Writers of America announces 2022 Spur Award winners